Stocks / Amryt Pharma (LSE: AMYT) / LSE:AMYT (Amryt Pharma)About amytAmryt looks to acquire, build, develop and subsequently monetise drug candidates focused on treating orphan diseases. Summary Profile Price History Financials Peer Comparison Share Info Performance Dividends Events Amryt Pharma (LSE: AMYT) Latest News Investing Articles Cheap UK shares: 1 I am considering right now 10 September, 2021 | Jabran Khan Jabran Khan is always on the lookout for cheap UK shares. Here is one FTSE AIM pick he is currently… Read more » Investing Articles 3 cheap UK shares I’d buy right now 16 August, 2021 | Royston Wild I'm searching for the best low-cost UK shares to buy as we head towards September. Here are three stocks on… Read more » Investing Articles I think this AIM stock’s price could surge…but I am being patient 31 October, 2019 | James J. McCombie Amryt Pharma (LSE: AMYT) might just have the revenues to get its exciting pipeline assets to market now. Read more » Investing Articles 2 under-the-radar stocks I’d consider in September 4 September, 2017 | Royston Wild Royston Wild looks at two little-known London stocks that could make you solid returns. Read more »
Investing Articles Cheap UK shares: 1 I am considering right now 10 September, 2021 | Jabran Khan Jabran Khan is always on the lookout for cheap UK shares. Here is one FTSE AIM pick he is currently… Read more »
Investing Articles 3 cheap UK shares I’d buy right now 16 August, 2021 | Royston Wild I'm searching for the best low-cost UK shares to buy as we head towards September. Here are three stocks on… Read more »
Investing Articles I think this AIM stock’s price could surge…but I am being patient 31 October, 2019 | James J. McCombie Amryt Pharma (LSE: AMYT) might just have the revenues to get its exciting pipeline assets to market now. Read more »
Investing Articles 2 under-the-radar stocks I’d consider in September 4 September, 2017 | Royston Wild Royston Wild looks at two little-known London stocks that could make you solid returns. Read more »